Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1381-1390 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|April 1, 2024
Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsiesQifei Dong, Changming Wang, Deyun Shen, et al.
The Prostate|September 30, 2024
Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancerMustafa Dinckal, Kasim Emre Ergun, Mustafa Serdar Kalemci, et al.
The Prostate|September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCaNobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
The Prostate|September 16, 2024
Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancerTaku Kato, Eiji Sugihara, Yuko Hata, et al.
The Prostate|September 16, 2024
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, et al.
The Prostate|September 23, 2024
Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case seriesElizabeth U Tran, Eric Royz, Kyra Yamamoto, et al.
The Prostate|March 7, 2024
Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network systemRichard Bennett, Eric V Li, Austin Y Ho, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
The Prostate|November 9, 2023
Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severitySarah A Mullen, Dipanwita Das, Negin Ziamiavaghi, et al.
The Prostate|November 14, 2023
Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasiaAntonio C H Mariotti, Vitor Heidrich, Lilian T Inoue, et al.
Pageof 592

Showing results (1381-1390 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|April 1, 2024
Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsiesQifei Dong, Changming Wang, Deyun Shen, et al.
The Prostate|September 30, 2024
Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancerMustafa Dinckal, Kasim Emre Ergun, Mustafa Serdar Kalemci, et al.
The Prostate|September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCaNobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
The Prostate|September 16, 2024
Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancerTaku Kato, Eiji Sugihara, Yuko Hata, et al.
The Prostate|September 16, 2024
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, et al.
The Prostate|September 23, 2024
Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case seriesElizabeth U Tran, Eric Royz, Kyra Yamamoto, et al.
The Prostate|March 7, 2024
Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network systemRichard Bennett, Eric V Li, Austin Y Ho, et al.
The Prostate|November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessChanning J Paller, Pedro C Barata, Justin Lorentz, et al.
The Prostate|November 9, 2023
Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severitySarah A Mullen, Dipanwita Das, Negin Ziamiavaghi, et al.
The Prostate|November 14, 2023
Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasiaAntonio C H Mariotti, Vitor Heidrich, Lilian T Inoue, et al.
Pageof 592